One Stop Shop for All Your Market Research Reports

Hirudin Market, Global Outlook and Forecast 2023-2029

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results. This report aims to provide a comprehensive presentation of the global market for Hirudin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hirudin. This report contains market size and forecasts of Hirudin in global, including the following market information: Global Hirudin Market Revenue, 2018-2023, 2024-2029, ($ millions) Global Hirudin Market Sales, 2018-2023, 2024-2029, (K MT) Global top five Hirudin companies in 2022 (%) The global Hirudin market was valued at US$ 4090.1 million in 2022 and is projected to reach US$ 5018.9 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hirudin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Hirudin Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT) Global Hirudin Market Segment Percentages, by Type, 2022 (%) Natural Hirudin Recombinant Hirudin Global Hirudin Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT) Global Hirudin Market Segment Percentages, by Application, 2022 (%) Thrombosis Disease Tumor Disease Others Global Hirudin Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT) Global Hirudin Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Hirudin revenues in global market, 2018-2023 (Estimated), ($ millions) Key companies Hirudin revenues share in global market, 2022 (%) Key companies Hirudin sales in global market, 2018-2023 (Estimated), (K MT) Key companies Hirudin sales share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: The Medicines Company Keyken Minapharm Abbott SALUBRIS Pfizer, Inc Teva Pharmaceutical Industries Ltd DUOPUTAI Pentapharm Outline of Major Chapters: Chapter 1: Introduces the definition of Hirudin, market overview. Chapter 2: Global Hirudin market size in revenue and volume. Chapter 3: Detailed analysis of Hirudin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Hirudin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global Hirudin capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports 1.1 Hirudin Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Hirudin Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3250
Multi User US $4225
Corporate User US $4875
About this Report
Report ID 1416434
Category
  • Chemicals and Materials
Published on 24-Jan
Number of Pages 72
Publisher Name Market Monitor Global
Editor Rating
★★★★★
★★★★★
(28)